In particular, anti-MPO antibodies have been reported in 4–36% of patients with idiopathic interstitial pneumonia, including IPF, while the occurrence of MPA has been described in a range from 1.7 to 25.7% of patients [20,21]. This evidence concerns the gene MPO and idiopathic pulmonary fibrosis.